Medical communications company Frontline Medical Communications has announced that Dr. Howard A. "Skip" Burris III, an Editor for both JCSO (Journal of Community and Supportive OncologyTM) and Oncology Practice®, has been elected to serve as President of the American Society of Clinical Oncology (ASCO) for the 2019-2020 term.
Dr. Burris is the chief medical officer and president of clinical operations at the Sarah Cannon Research Institute in Nashville, Tenn. He established the first community-based phase 1 drug development program in Nashville, which went on to become the Sarah Cannon Research Institute. He led the first-in-human studies for many now-approved drugs that have changed the standard of care for several types of cancers including docetaxel and ado-trastuzumab emtansine in breast cancer and everolimus in kidney cancer.
Dr. Burris has authored more than 300 publications and more than 450 abstracts, and was named a Giant of Cancer Care during the 2014 ASCO annual meeting.
Brought to you by Scope e-Knowledge Center, a trusted global partner for digital content transformation solutions - Abstracting & Indexing (A&I), Knowledge Modeling (Taxonomies, Thesauri and Ontologies), and Metadata Enrichment & Entity Extraction.
